{"id":697,"date":"2004-03-08T00:00:00","date_gmt":"2007-04-09T11:43:26","guid":{"rendered":""},"modified":"2022-09-25T21:26:43","modified_gmt":"2022-09-26T01:26:43","slug":"global-access-to-medicines-will-canada-meet-the-challenge-supplementary-submission-to-the-standing-committee-on-industry-science-and-technology-regarding-bill-c-9-an-act-to-amend-the-patent-act","status":"publish","type":"publication22","link":"https:\/\/www.hivlegalnetwork.ca\/site\/global-access-to-medicines-will-canada-meet-the-challenge-supplementary-submission-to-the-standing-committee-on-industry-science-and-technology-regarding-bill-c-9-an-act-to-amend-the-patent-act\/","title":{"rendered":"Global Access to Medicines: Will Canada Meet the Challenge? &#8211; Supplementary submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act"},"content":{"rendered":"The Standing Committee has asked that we provide our views regarding the \u201calternatives\u201d to the right of refusal that have been put forward by other witnesses appearing before the Committee. We address several of the most important points that have been put before the Committee.<br \/>\n<!-- Jean Chr\u00e9tien Pledge to Africa, Bill C-9, patent, Patent Act, Food and Drugs Act, compulsory licensing, export, developing countries, right of first refusal, generic, manufacturer, producer, pharmaceutical, product, access to medicines, World Trade Organization, Doha Declaration, Decision of 30 August 2003 \/ August 30, 2003 Decision, TRIPS, Agreement on Trade-Related Aspects of Intellectual Property Rights, Standing Committee on Industry, Science and Technology, House of Commons, Parliament, Right to health, Schedule 1 --><p class=\"download-link-button\"><a class=\"download-link en\" title=\"Global Access to Medicines: Will Canada Meet the Challenge? \u2013 Supplementary submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act\" href=\"https:\/\/www.hivlegalnetwork.ca\/site\/download\/9924\/?tmstv=1777602633\" rel=\"nofollow\">\r\n\tDownload<\/a><\/p>","protected":false},"author":1,"featured_media":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"publication_topics":[145],"publication_type":[170],"publication_language":[184,185],"class_list":["post-697","publication22","type-publication22","status-publish","hentry","publication_topics-access-to-medicines","publication_type-advocacy","publication_language-english","publication_language-french"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22"}],"about":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/types\/publication22"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":4,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/697\/revisions"}],"predecessor-version":[{"id":20750,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication22\/697\/revisions\/20750"}],"wp:attachment":[{"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/media?parent=697"}],"wp:term":[{"taxonomy":"publication_topics","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_topics?post=697"},{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_type?post=697"},{"taxonomy":"publication_language","embeddable":true,"href":"https:\/\/www.hivlegalnetwork.ca\/site\/wp-json\/wp\/v2\/publication_language?post=697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}